Update: Market Chatter: Takeda, Other Biotech Firms to Announce New Drug Pricing Deals With White House

03:58 PM EDT, 08/31/2026 (MT Newswires) -- (Updates with Bayer's response in the last paragraph.) Takeda Pharmaceutical (TAK), Bayer, CSL, and other mid-size biotech firms are set to announce new pricing deals with the White House on Monday, the Financial Times reported, citing two sources familiar with the matter. The deals will be similar to those finalized by large pharmaceutical companies in which they agreed to lower prices in exchange for tariff relief, according to the report. A Bayer spokesperson said the company had no information to share on the Most Favored Nation drug pricing policy at the moment, while Takeda and CSL did not immediately respond to requests for comment from MT Newswires. (Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.) Price: 18.00, Change: -0.04, Percent Change: -0.19